Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

Conditions: Solid Tumor, Adult; BRCA1 Mutation; BRCA2 Mutation; Ovarian Cancer; Breast Cancer; Prostate Cancer Interventions: Drug: ACE-86225106 tablet Sponsors: Acerand Therapeutics (Shanghai) Limited Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials